Therefore, in this study, we only demonstrated that ALKBH5 increased the percentage of SP cells and CD138-/CD34- myeloma stem cells by activating cancer stem cell related HIPPO pathway signalling and promoting the expression of pluripotency factors NANOG, SOX2 and OCT4. This evidence concerns the gene POU5F1 and plasma cell myeloma.